Lotus Pharmaceuticals, Inc.
LTUS
$0.0053
-$0.0007-11.67%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | -91.59% | -62.84% | -34.07% | -12.22% | 2.45% |
| Total Depreciation and Amortization | -4.56% | 1.23% | 6.87% | 13.16% | 79.80% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -100.00% | -87.44% | -66.30% |
| Total Other Non-Cash Items | 185.66% | 222.59% | 293.29% | 247.48% | 624.66% |
| Change in Net Operating Assets | 376.61% | 434.23% | 47.28% | -80.29% | -107.37% |
| Cash from Operations | -26.78% | 2.46% | 5.43% | -14.62% | -46.17% |
| Capital Expenditure | -7.58% | -57.62% | -98.91% | -164.85% | -16.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 69.59% |
| Cash from Investing | 28.41% | -0.43% | -4.83% | -2.61% | 40.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 133.45% | 911.76% | 2,037.14% | 1,460.47% | 787.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.60% | 74.42% | 279.25% | -197.71% | -1,645.96% |